CompletedNCT01597063
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
Studying Down syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sequenom, Inc.
- Principal Investigator
- Daniel Grossu, MDSequenom, Inc.
- Intervention
- SEQureDx Trisomy Test(device)
- Enrollment
- 3333 enrolled
- Eligibility
- 18-34 years · FEMALE
- Timeline
- 2012 – 2015
Study locations (27)
- University of South Alabama, Mobile, Alabama, United States
- New Horizon Women's Care, Chandler, Arizona, United States
- Precision Trials, Phoenix, Arizona, United States
- Visions Clinical Research Tuscon, Tucson, Arizona, United States
- Descanso OBGYN, Glendale, California, United States
- Woodglen Medical Group, Glendora, California, United States
- White Memorial GYN/OB Medical Group, Los Angeles, California, United States
- Fair Oaks Women's Health, Pasadena, California, United States
- IGO Medical Group, San Diego, California, United States
- West Coast OBGYN, San Diego, California, United States
- Women's Health Care Research, San Diego, California, United States
- Women's Clinical Research, Vista, California, United States
- Hawaii Pacific Health, Honolulu, Hawaii, United States
- University of Iowa Health Care, Iowa City, Iowa, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- +12 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01597063 on ClinicalTrials.govOther trials for Down syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07416201Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without ThymectomyNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNANCT07484464Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down SyndromeRiphah International University
- RECRUITINGNCT07195253Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down SyndromeHospices Civils de Lyon
- RECRUITINGNANCT07296861HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down SyndromeUNC Lineberger Comprehensive Cancer Center
- ENROLLING BY INVITATIONNCT07413224Qualitative Effects of AEF0217 in Down Syndrome PeopleAelis Farma
- RECRUITINGPHASE4NCT07280468Endotype DIrected Treatment for OSA in Down SyndromeUniversity of Arizona
- RECRUITINGNANCT07425769Adapting RDAD for DSUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07242638Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down SyndromeIcahn School of Medicine at Mount Sinai